Charles R. Roe, M.D.
Dr. Charles Roe is medical director of
the Institute of Metabolic Disease at Baylor
University Medical Center in Dallas. He received
his M.D. in 1964 at Duke University Medical
Center, where he also completed his residency
in pediatrics and completed a fellowship in
metabolic disease. He received two years of additional
training in the department of biochemistry
at Brandeis University. During his fellowship
training he developed the creatine kinase MB
isoenzyme test for the recognition of acute heart
attacks, which has become a gold standard for
diagnosis worldwide. He served as professor of
pediatrics and the chief of the division of genetics
and metabolism at Duke Medical Center
from 1975 to 1995 before assuming his current
position. Dr. Roe has authored more than 200
publications in the field of pediatrics and inherited
metabolic disease and has characterized four
new inherited diseases during his career. His primary
research interest is in the field of inherited
metabolic defects involving mitochondrial fat
oxidation and branched-chain amino acid degradation.
He developed a world-renowned supplemental
newborn screening program at Baylor
Health Care System hospitals which tests infants
for more than 30 inherited metabolic diseases
not detected by routine state newborn screening.
Dr. Roe's CV
To contact Dr. Roe, feel free to email him at CharlesR@baylorhealth.edu.